456 related articles for article (PubMed ID: 33075480)
1. Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.
Arnsten AFT
Neurobiol Learn Mem; 2020 Dec; 176():107327. PubMed ID: 33075480
[TBL] [Abstract][Full Text] [Related]
2. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.
Arnsten AF; Jin LE
Yale J Biol Med; 2012 Mar; 85(1):45-58. PubMed ID: 22461743
[TBL] [Abstract][Full Text] [Related]
3. Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals.
Ramos BP; Stark D; Verduzco L; van Dyck CH; Arnsten AF
Learn Mem; 2006; 13(6):770-6. PubMed ID: 17101879
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.
Franowicz JS; Kessler LE; Borja CM; Kobilka BK; Limbird LE; Arnsten AF
J Neurosci; 2002 Oct; 22(19):8771-7. PubMed ID: 12351753
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).
Alamo C; López-Muñoz F; Sánchez-García J
Actas Esp Psiquiatr; 2016 May; 44(3):107-12. PubMed ID: 27254403
[TBL] [Abstract][Full Text] [Related]
6. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions.
Fukuyama K; Nakano T; Shiroyama T; Okada M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923533
[TBL] [Abstract][Full Text] [Related]
7. Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline.
Kauser H; Sahu S; Kumar S; Panjwani U
Neuroscience; 2013 Dec; 254():110-9. PubMed ID: 24056194
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine influences on dorsolateral prefrontal cortical networks.
Arnsten AF
Biol Psychiatry; 2011 Jun; 69(12):e89-99. PubMed ID: 21489408
[TBL] [Abstract][Full Text] [Related]
9. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex.
Wang M; Ramos BP; Paspalas CD; Shu Y; Simen A; Duque A; Vijayraghavan S; Brennan A; Dudley A; Nou E; Mazer JA; McCormick DA; Arnsten AF
Cell; 2007 Apr; 129(2):397-410. PubMed ID: 17448997
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
Arnsten AF; Pliszka SR
Pharmacol Biochem Behav; 2011 Aug; 99(2):211-6. PubMed ID: 21295057
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat.
Ji XH; Ji JZ; Zhang H; Li BM
Neuropsychopharmacology; 2008 Aug; 33(9):2263-71. PubMed ID: 17957212
[TBL] [Abstract][Full Text] [Related]
12. Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress.
Hains AB; Yabe Y; Arnsten AF
Neurobiol Stress; 2015; 2():1-9. PubMed ID: 25664335
[TBL] [Abstract][Full Text] [Related]
13. Neuronal basis of age-related working memory decline.
Wang M; Gamo NJ; Yang Y; Jin LE; Wang XJ; Laubach M; Mazer JA; Lee D; Arnsten AF
Nature; 2011 Jul; 476(7359):210-3. PubMed ID: 21796118
[TBL] [Abstract][Full Text] [Related]
14. The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.
Arnsten AF
Expert Rev Neurother; 2010 Oct; 10(10):1595-605. PubMed ID: 20925474
[TBL] [Abstract][Full Text] [Related]
15. Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels.
Gamo NJ; Lur G; Higley MJ; Wang M; Paspalas CD; Vijayraghavan S; Yang Y; Ramos BP; Peng K; Kata A; Boven L; Lin F; Roman L; Lee D; Arnsten AF
Biol Psychiatry; 2015 Dec; 78(12):860-70. PubMed ID: 25731884
[TBL] [Abstract][Full Text] [Related]
16. Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders.
Arnsten AFT; Ishizawa Y; Xie Z
Mol Psychiatry; 2023 Nov; 28(11):4540-4552. PubMed ID: 37029295
[TBL] [Abstract][Full Text] [Related]
17. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
Schmeichel BE; Zemlan FP; Berridge CW
Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
Kawaura K; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2A adrenergic receptor agonist, guanfacine, attenuates cocaine-related impairments of inhibitory response control and working memory in animal models.
Terry AV; Callahan PM; Schade R; Kille NJ; Plagenhoef M
Pharmacol Biochem Behav; 2014 Nov; 126():63-72. PubMed ID: 25242808
[TBL] [Abstract][Full Text] [Related]
20. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
Arnsten AF
CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
